Cadial receives USFDA approval for Chlorthalidone
Zydus Cadila has received final USFDA to market Chlorthalidone tablets, used to treat high blood pressure. The drug will be marketed in the strengths of […]
Zydus Cadila has received final USFDA to market Chlorthalidone tablets, used to treat high blood pressure. The drug will be marketed in the strengths of […]
Glenmark Pharma has received final USFDA approval to market a generic version of AstraZeneca’s Nexium, used to treat acid reflux. The drug esomeprazole magnesium delayed-release […]
Alembic Pharmaceuticals has received final USFDA approval for Tadalafil tablets, indicated for the treatment of erectile dysfunction. The drug will be marketed in strengths of […]
Zydus Cadila has received final USFDA approval to market Ambrisentan tablets in in strengths of 5 mg and 10 mg in the American market. The […]
Alembic Pharmaceuticals has received USFDA approval for Azelastine Hydrochloride Ophthalmic Solution used for the treatment of allergic conjunctivitis. The drug is equivalent of Optivar Ophthalmic […]
Lupin has received final USFDA approval to market Sildenafil tablets, used in the treatment of erectile dysfunction in USA. The drug is a generic version […]
Glenmark Pharmaceuticals has received final USFDA approval for its generic version of BenzaClin gel used in the treatment of acne. The ointment gel Clindamycin and […]
Cadila has received USFDA approval for Potassium Chloride extended-release capsules to market the same in United States. The product is used to treat or prevent […]
Unichem Laboratories has received USFDA approval for the drug Allopurinol tablets in the strengths of 100 mg and 300 mg. The Allopurinol tablet is a […]
Lupin has received USFDA approval to market its generic Atorvastatin Calcium tablets, used for lowering cholesterol, in the American market. The product will be made […]
Copyright © 2024 | WordPress Theme by MH Themes